The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Hereditary Hemochromatosis — A New Look at an Old Disease
Abstract
For many years, hereditary hemochromatosis was regarded as a clinically and genetically unique entity marked by a classic presentation consisting of diabetes, bronze skin pigmentation, and cirrhosis. In 1996, identification of “the hemochromatosis gene,” HFE, was reported; since then, several other iron-metabolism genes have also been identified. This article reviews the current understanding and management of hereditary iron-overload disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The HFE mutation leads to an impaired formation of hepcidin and thus to an iron deficiency phenotype of MΦs, whereas excessively absorbed iron is stored in parenchymal organs such as the liver, heart, or pancreas.”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [201]
In the citing paper
“Conversely, individuals with insufficient hepcidin production, suffer from iron-overload in the blood, and hepatitis (Pietrangelo, 2004).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Pietrangelo, 2004
In the citing paper
“HFE mutations, especially the homozygous C282Y substitution, result in type I (AKA classical) hereditary hemochromatosis (HH) (Camaschella et al., 2002; Pietrangelo, 2004; Weiss, 2010)”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Pietrangelo, 2004
In the citing paper
“HH is characterized by reduced serum levels of the antimicrobial peptide Hamp (hepcidin) and increased duodenal absorption of iron via divalent metal transporter 1 (Dmt1) and ferroportin 1 (Fpn1) despite progressive iron overload in parenchymal organs including the liver, pancreas, and heart (Zoller et al., 1999, 2001; Bridle et al., 2003; Pietrangelo, 2004; Bardou-Jacquet et al., 2013).”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Pietrangelo, 2004
In the citing paper
“Hfe deficiency results in reduced Hamp production and increased serum iron levels (Pietrangelo, 2004).”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Pietrangelo, 2004
In the citing paper
“The proximal region of the human ferritin H gene was activated by NF-Y and p300 during hemin-induced FLC differentiation, and this proximal region was also responsible for cAMP (80, 194, 248).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [248]
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion
den Dunnen, J. T., & Antonarakis, S. E. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1 · Cited by 1,757
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis
Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H. J., & Strohmeyer, G. W. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132004 · Cited by 1,063
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860
Research works printed but not linked: 10
- Troisier M, 1871, Bull Soc Anat Paris, 44, 231
- von Recklinghausen FD, 1889, Tageblatt Versammlung Dtsche Naturforscher Arzte Heidelberg, 62, 324
- Sheldon JH. Haemochromatosis. London: Oxford University Press, 1935.
- Simon M, 1975, Nouv Presse Med, 4, 1432
- Simon M, 1987, Am J Hum Genet, 41, 89
- Cook JD, 1973, Am J Pathol, 72, 337
- Smith PM, 1969, Clin Sci, 37, 519
- McLaren GD, 1991, J Lab Clin Med, 117, 390
- Powell LW, 2002, Semin Gastrointest Dis, 13, 80
- Hayashi A, 1993, Am J Hum Genet, 53, 201
Cited by
Sorted by citations
Items 201–300 of 991
Koyama, C., Hayashi, H., Wakusawa, S., Ueno, T., Yano, M., Katano, Y., Goto, H., & Kidokoro, R. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.024 · Cited by 59
Hepcidin and iron metabolism: From laboratory to clinical implications
Franchini, M., Montagnana, M., & Lippi, G. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.003 · Cited by 60
Diagnostic value of transferrin
Szőke, D., & Panteghini, M. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.04.021 · Cited by 59
p53 tumor suppressor and iron homeostasis
Zhang, J., & Chen, X. (2018) · FEBS Journal · doi:10.1111/febs.14638 · Cited by 59
Revisiting Hereditary Hemochromatosis: Current Concepts and Progress
Yen, A. W., Fancher, T. L., & Bowlus, C. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.041 · Cited by 58
Feng, W., Xiao, Y., Zhao, C., Zhang, Z., Liu, W., Ma, J., Ganz, T., Zhang, J., & Liu, S. (2022) · Advanced Science · doi:10.1002/advs.202202679 · Cited by 57
Restaino, G., Meloni, A., Positano, V., Missere, M., Rossi, G., Calandriello, L., Keilberg, P., Mattioni, O., Maggio, A., Lombardi, M., et al. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22640 · Cited by 57
Genetic testing and common disorders in a public health framework
van El, C. G., & Cornel, M. C. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.176 · Cited by 57
Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice
Sebastiani, G., & Pantopoulos, K. (2011) · Metallomics · doi:10.1039/c1mt00082a · Cited by 58
Riva, A., Trombini, P., Mariani, R., Salvioni, A., Coletti, S., Bonfadini, S., Paolini, V., Pozzi, M., Facchetti, R., Bovo, G., et al. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4745 · Cited by 57
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis
Bozzini, C., Campostrini, N., Trombini, P., Nemeth, E., Castagna, A., Tenuti, I., Corrocher, R., Camaschella, C., Ganz, T., Olivieri, O., et al. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.10.001 · Cited by 57
Absorption of Manganese and Iron in a Mouse Model of Hemochromatosis
Kim, J., Buckett, P. D., & Wessling‐Resnick, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064944 · Cited by 55
Puliyel, M. M., Mainous, A. G., Berdoukas, V. A., & Coates, T. D. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.10.861 · Cited by 54
Diagnosis and treatment of hereditary hemochromatosis: an update
Kanwar, P., & Kowdley, K. V. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2013.816114 · Cited by 57
Contemporary dental photography: selection and application.
Terry, D. A., Snow, S. R., & McLaren, E. A. (2008) · PubMed · Cited by 57
Pietrangelo, A. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111226 · Cited by 57
Self-citationPathways for the regulation of body iron homeostasis in response to experimental iron overload
Theurl, I., Ludwiczek, S., Eller, K., Seifert, M., Artner, E., Brunner, P., & Weiß, G. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.030 · Cited by 57
McLaren, G. D., & Gordeuk, V. R. (2009) · Hematology · doi:10.1182/asheducation-2009.1.195 · Cited by 57
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis
Roetto, A., & Camaschella, C. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.09.004 · Cited by 55
Recent developments on 3-hydroxy-4-pyridinones with respect to their clinical applications
Santos, M. A. (2008) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2008.01.033 · Cited by 54
Iron overload in myelodysplastic syndromes: A Canadian consensus guideline
Wells, R. A., Leber, B. F., Buckstein, R. J., Lipton, J. H., Hasegawa, W. S., Grewal, K. S., Yee, K. W. L., Olney, H. J., Larratt, L. M., Vickars, L. M., et al. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.02.021 · Cited by 55
Hulgan, T., Tebas, P., Canter, J. A., Mulligan, K. M., Haas, D. W., Dubé, M. P., Grinspoon, S. K., Robbins, G. K., Motsinger‐Reif, A. A., & Kallianpur, A. R. (2008) · The Journal of Infectious Diseases · doi:10.1086/528697 · Cited by 53
Ganz, T., Aronoff, G. R., Gaillard, S., Goodnough, L. T., Macdougall, I. C., Mayer, G. J., Porto, G., Winkelmayer, W. C., & Wish, J. B. (2020) · Kidney Medicine · doi:10.1016/j.xkme.2020.01.006 · Cited by 54
Molecular and clinical aspects of iron homeostasis: from anemia to hemochromatosis
Nairz, M., & Weiß, G. (2006) · Wiener klinische Wochenschrift · doi:10.1007/s00508-006-0653-7 · Cited by 54
Iron Regulator Hepcidin Exhibits Antiviral Activity against Hepatitis C Virus
Liu, H., Trinh, T. L., Dong, H., Keith, R., Nelson, D. R., & Liu, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046631 · Cited by 53
Hepcidin: another culprit for complications in patients with chronic kidney disease?
Nakanishi, T., Hasuike, Y., Otaki, Y., Kida, A., Nonoguchi, H., & Kuragano, T. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr410 · Cited by 53
Jiang, X., Liu, Z., Lin, A., Xiang, L., & Shao, J.-Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-04069-x · Cited by 54
Molecular insights into the pathogenesis of hereditary haemochromatosis
Pietrangelo, A. (2006) · Gut · doi:10.1136/gut.2005.078063 · Cited by 53
Self-citationOutline of a medical genetics curriculum for internal medicine residency training programs
Riegert‐Johnson, D. L., Korf, B. R., Alford, R. L., Broder, M. I., Keats, B. J. B., Ormond, K. E., Pyeritz, R. E., & Watson, M. S. (2004) · Genetics in Medicine · doi:10.1097/01.gim.0000144561.77590.85 · Cited by 52
Valenti, L. V. C. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i22.2813 · Cited by 52
Leitch, J., Anderson, K., Gambhir, S., Millar, K., Robb, N. D., McHugh, S., & Kenny, G. N. C. (2004) · Anaesthesia · doi:10.1111/j.1365-2044.2004.03761.x · Cited by 53
Liver Diseases in the Hemochromatosis and Iron Overload Screening Study
Adams, P. C., Passmore, L. V., Chakrabarti, S., Reboussin, D. M., Acton, R. T., Barton, J. C., McLaren, G. D., Eckfeldt, J. H., Dawkins, F. W., Gordeuk, V. R., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.04.013 · Cited by 52
Liver iron content determination by magnetic resonance imaging
Τζιόμαλος, Κ. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i13.1587 · Cited by 53
The Pathogenesis of Hepatocellular Carcinoma
Kirstein, M. M., & Vogel, A. (2014) · Digestive Diseases · doi:10.1159/000360499 · Cited by 51
Heinicke, K., Baum, O., Ogunshola, O. O., Vogel, J., Stallmach, T., Wolfer, D. P., Keller, S., Weber, K., Wagner, P. D., Gassmann, M., et al. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00152.2006 · Cited by 51
Das, S. K., DesAulniers, J., Dyck, J. R. B., Kassiri, Z., & Oudit, G. Y. (2015) · Liver International · doi:10.1111/liv.12893 · Cited by 51
Das, S. K., Patel, V. B., Basu, R., Wang, W., DesAulniers, J., Kassiri, Z., & Oudit, G. Y. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.003456 · Cited by 54
Phenotypic expression in detected C282Y homozygous women depends on body mass index
Lainé, F., Jouannolle, A.-M., Morçet, J., Brigand, A., Pouchard, M., Lafraise, B., Mosser, J., David, V., & Deugnier, Y. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.027 · Cited by 51
Iron overload cardiomyopathy: Using the latest evidence to inform future applications
Kumfu, S., Chattipakorn, S. C., & Chattipakorn, N. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221076397 · Cited by 50
Crawford, D. H., Murphy, T. L., Ramm, L. E., Fletcher, L. M., Clouston, A. D., Anderson, G. J., Subramaniam, V. N., Powell, L. W., & Ramm, G. A. (2008) · Hepatology · doi:10.1002/hep.22650 · Cited by 50
Yun, S., & Vincelette, N. D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.02.006 · Cited by 52
Function of the hemochromatosis protein HFE: Lessons from animal models
Pantopoulos, K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6893 · Cited by 49
Recent advances in hereditary hemochromatosis
Franchini, M., & Veneri, D. (2005) · Annals of Hematology · doi:10.1007/s00277-005-1006-8 · Cited by 49
Demetz, E., Tymoszuk, P., Hilbe, R., Volani, C., Haschka, D., Heim, C., Auer, K., Lener, D., Zeiger, L. B., Pfeifhofer‐Obermair, C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa140 · Cited by 47
Hepcidin assay in serum by SELDI-TOF-MS and other approaches
Castagna, A., Campostrini, N., Zaninotto, F., & Girelli, D. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.08.003 · Cited by 49
Red Blood Cells: Exchange, Transfuse, or Deplete
Stüssi, G., Buser, A. S., & Holbro, A. (2019) · Transfusion Medicine and Hemotherapy · doi:10.1159/000504144 · Cited by 49
Complex confounder-corrected R2* mapping for liver iron quantification with MRI
Hernando, D., Cook, R. J., Qazi, N. H., Longhurst, C. A., Diamond, C. A., & Reeder, S. B. (2020) · European Radiology · doi:10.1007/s00330-020-07123-x · Cited by 48
Hepcidin and iron status among pregnant women in Bangladesh.
Schulze, K. J., Christian, P. S., Ruczinski, I., Ray, A. L., Nath, A., Wu, L. S. F., & Semba, R. D. (2008) · PubMed · Cited by 48
Influence of Lead on Repetitive Behavior and Dopamine Metabolism in a Mouse Model of Iron Overload
Chang, J., Kueon, C., & Kim, J. (2014) · Toxicological Research · doi:10.5487/tr.2014.30.4.267 · Cited by 47
Physiological implications of NTBI uptake by T lymphocytes
Pinto, J. P., Arezes, J., Dias, V., Oliveira, S. J., Vieira, I. H., Costa, M., Vos, M. R. J., Carlsson, A., Rikers, Y. G. M., Rangel, M., et al. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00024 · Cited by 47
Treatment of hyperferritinemia
Beaton, M. D., & Adams, P. C. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30923-8 · Cited by 47
Hrušková, K., Potůčková, E., Hergeselová, T., Liptáková, L., Hašková, P., Mingas, P.-D., Kovařı́ková, P., Šimůnek, T., & Vávrová, K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.015 · Cited by 47
Advances in understanding the molecular basis for the regulation of dietary iron absorption
Fleming, R. E. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000153362.98276.db · Cited by 47
Nairz, M., Schroll, A., Haschka, D., Dichtl, S., Tymoszuk, P., Demetz, E., Moser, P., Haas, H., Fang, F. C., Theurl, I., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00110 · Cited by 46
Cardiovascular effects of xenon and nitrous oxide in patients during fentanyl‐midazolam anaesthesia*
Goto, T., Hanne, P., Ishiguro, Y., Ichinose, F., Niimi, Y., & Morita, S. (2004) · Anaesthesia · doi:10.1111/j.1365-2044.2004.03900.x · Cited by 47
Janssen, M. C. H., & Swinkels, D. W. (2009) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2009.02.004 · Cited by 46
Létocart, É., Gac, G. L., Majore, S., Ka, C., Radio, F. C., Gourlaouen, I., Bernardo, C. D., Férec, C., & Grammatico, P. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07834.x · Cited by 46
Pharmacogenetics of Nucleoside Reverse-Transcriptase Inhibitor-Associated Peripheral Neuropathy
Kallianpur, A. R., & Hulgan, T. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.14 · Cited by 46
Österreicher, C., Datz, C., Stickel, F., Hellerbrand, C., Penz, M., HOFER, H., Wrba, F., Penner, E., Schuppan, D., & Ferenci, P. (2005) · Cytokine · doi:10.1016/j.cyto.2005.03.005 · Cited by 48
Equitani, F., Fernández‐Real, J. M., MENICHELLA, G., Koch, M., Calvani, M., Nobili, V., Mingrone, G., & Manco, M. (2007) · Diabetes Care · doi:10.2337/dc07-0939 · Cited by 46
Liver and biliary tract disease
Collier, J. D., & Webster, G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-3085-7.00023-7 · Cited by 46
Huh-7: A Human “Hemochromatotic” Cell Line
Vecchi, C., Montosi, G., & Pietrangelo, A. (2009) · Hepatology · doi:10.1002/hep.23410 · Cited by 45
Self-citationThe global burden of iron overload
Wood, M. J., Skoien, R., & Powell, L. W. (2009) · Hepatology International · doi:10.1007/s12072-009-9144-z · Cited by 45
Hemochromatosis in Italy in the Last 30 Years: Role of Genetic and Acquired Factors
Fracanzani, A. L., Piperno, A., Valenti, L. V. C., Fraquelli, M., Coletti, S., Maraschi, A., Consonni, D., Coviello, E., Conte, D., & Fargion, S. R. (2009) · Hepatology · doi:10.1002/hep.23333 · Cited by 45
Tseng, S., Liu, P., Lee, Y., Wu, Z., Huang, C.-C., Cheng, C., & Tung, K. (2018) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2018/6976897 · Cited by 44
Elmberg, M., Hultcrantz, R. W., Simard, J. F., Carlsson, Å., & Askling, J. (2012) · Arthritis Care & Research · doi:10.1002/acr.21883 · Cited by 44
Gordeuk, V. R., Reboussin, D. M., McLaren, C. E., Barton, J. C., Acton, R. T., McLaren, G. D., Harris, E. L., Reiss, J. A., Adams, P. C., Speechley, M. R., et al. (2008) · American Journal of Hematology · doi:10.1002/ajh.21179 · Cited by 44
Emerging Concepts in Nutrigenomics: A Preview of What Is to Come
KAUWELL, G. P. A. (2005) · Nutrition in Clinical Practice · doi:10.1177/011542650502000175 · Cited by 43
Lawless, M. W., Mankan, A. K., White, M., O’Dwyer, M. J., & Norris, S. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-30 · Cited by 44
On myocardial siderosis and left ventricular dysfunction in hemochromatosis
Carpenter, J., Grasso, A. E., Porter, J. B., Shah, F., Dooley, J. S., & Pennell, D. J. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-24 · Cited by 43
Horniblow, R. D., Henesy, D., Iqbal, T. H., & Tselepis, C. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600692 · Cited by 45
Iron status, body size, and growth in the first 2 years of life
McCarthy, E. K., Chaoimh, C. N., Kenny, L. C., Hourihane, J. O., Irvine, A. D., Murray, D. M., & Kiely, M. E. (2017) · Maternal and Child Nutrition · doi:10.1111/mcn.12458 · Cited by 43
Polymeric Nanoparticles Enhance the Ability of Deferoxamine To Deplete Hepatic and Systemic Iron
Guo, S., Liu, G., Frazer, D. M., Liu, T., You, L., Xu, J., Wang, Y., Anderson, G. J., & Nie, G. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02428 · Cited by 43
Constante, M., Wang, D., Raymond, V., Bilodeau, M., & Santos, M. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060437 · Cited by 42
Machado, C. D. C., & Dinis‐Oliveira, R. J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072591 · Cited by 44
Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology
Vela, D. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.111 · Cited by 41
Koyama, C., Wakusawa, S., Hayashi, H., Ueno, T., SUZUKI, R., Yano, M., Saito, H., & OKAZAKI, T. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.990 · Cited by 41
Moksnes, M. R., Graham, S. E., Wu, K.-H., Hansen, A. F., Taliun, S. A. G., Zhou, W., Thorstensen, K., Fritsche, L. G., Gill, D., Mason, A. M., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03529-z · Cited by 41
Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis
Sikorska, K., Bernat, A., & Wróblewska, A. (2016) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(16)60135-2 · Cited by 41
Hypogonadotropic hypogonadism in men with hereditary hemochromatosis
Osta, R. E., Grandpré, N., Monnin, N., Hubert, J., & Koscinski, I. (2017) · Basic and Clinical Andrology · doi:10.1186/s12610-017-0057-8 · Cited by 40
Genetic Background of Primary Iron Overload Syndromes in Japan
Hayashi, H., Wakusawa, S., Motonishi, S., Miyamoto, K., Okada, H., Inagaki, Y., & Ikeda, T. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1876 · Cited by 40
Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells
Fillebeen, C., Muckenthaler, M. U., Andriopoulos, B., Bisaillon, M., Mounir, Z., Hentze, M. W., Koromilas, A. E., & Pantopoulos, K. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.035 · Cited by 40
Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
Espina, S., Deza, D. C., Monterde, V. B., Domper-Arnal, M. J., García, S. G., & Luè, A. (2023) · Nutrients · doi:10.3390/nu15153487 · Cited by 43
High risk of cardiovascular disease in iron overload patients
Meroño, T., Rosso, L. A. G., Sorroche, P. B., Boero, L. E., Arbelbide, J. A., & Brites, F. D. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02429.x · Cited by 40
Increased Plasma Ferritin Concentration and Low-Grade Inflammation—A Mendelian Randomization Study
Moen, I. W., Bergholdt, H. K. M., Mandrup-Poulsen, T. R., Nordestgaard, B. G., & Ellervik, C. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.276055 · Cited by 39
Altered Iron Metabolism in Lymphocytes from Subjects with Restless Legs Syndrome
Earley, C. J., Ponnuru, P., Wang, X., Patton, S. M., Connor, J. R., Beard, J. L., Taub, D. D., & Allen, R. P. (2008) · SLEEP · doi:10.1093/sleep/31.6.847 · Cited by 39
Petrak, J., Myslivcova, D., Man, P., Cmejla, R., Cmejlova, J., Vyoral, D., Elleder, M., & Vulpe, C. D. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00455.2006 · Cited by 38
Rammos, A., Meladinis, V., Vovas, G., & Patsouras, D. (2017) · Radiology Research and Practice · doi:10.1155/2017/2874902 · Cited by 38
Impaired Iron Transport Activity of Ferroportin 1 in Hereditary Iron Overload
McGregor, J., Shayeghi, M., Vulpe, C. D., Anderson, G. J., Pietrangelo, A., Simpson, R. J., & McKie, A. T. (2005) · The Journal of Membrane Biology · doi:10.1007/s00232-005-0768-1 · Cited by 39
Self-citationVisão atual da hemocromatose hereditária
Cançado, R. D., & CHIATTONE, C. S. (2010) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842010000600011 · Cited by 37
Valenti, L. V. C., Fracanzani, A. L., Rametta, R., Fraquelli, M., Soverini, G., Pelusi, S., Dongiovanni, P., Conte, D., & Fargion, S. R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.041 · Cited by 37
Kotze, M. J., van Velden, D. P., van Rensburg, S. J., & Erasmus, R. T. (2009) · PubMed Central · Cited by 37
Ellervik, C., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02404.x · Cited by 37
Jenkins, Z. A., Hagar, W., Bowlus, C. L., Johansson, H. E., Harmatz, P., Vichinsky, E. P., & Theil, E. C. (2007) · Pediatric Hematology and Oncology · doi:10.1080/08880010701360700 · Cited by 36
Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload.
Bondi, A., Valentino, P., Daraio, F., Porporato, P. E., Gramaglia, E., Carturan, S., Gottardi, E. M., Camaschella, C., & Roetto, A. (2005) · PubMed · Cited by 36
Iron Stores Modulate Hepatic Hepcidin Expression by an HFE-Independent Pathway
Gehrke, S. G., Herrmann, T. R. W., Kulaksiz, H., Merle, U., Bents, K., Kaiser, I., Riedel, H.-D., & Stremmel, W. (2005) · Digestion · doi:10.1159/000087400 · Cited by 37
Adams, P. C., Reboussin, D. M., Leiendecker-Foster, C., Moses, G. C., McLaren, G. D., McLaren, C. E., Dawkins, F. W., Kasvosve, I., Acton, R. T., Barton, J. C., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.048371 · Cited by 37
Aggett, P. J. (2012) · doi:10.1002/9781119946045.ch33 · Cited by 37
Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation
Wang, Q., Du, J., Duan, Z., Guo, S.-B., Sun, X., & Liu, Z. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i19.2921 · Cited by 36
Different forms of iron accumulation in the liver on MRI
İdilman, İ. S., Akata, D., Ozmen, M. N., & Karçaaltıncaba, M. (2015) · Diagnostic and Interventional Radiology · doi:10.5152/dir.2015.15094 · Cited by 36
Metadata
- Authors
- Pietrangelo, A.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Pietrangelo, Antonello
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-06-03
- Volume
- 350
- Issue
- 23
- Pages
- 2383-2397
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2168051647
- Cited by
- 992
- References
- 97
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 16 · 2023: 17 · 2022: 22 · 2021: 18 · 2020: 21 · 2019: 21 · 2018: 38 · 2017: 38 · 2016: 37 · 2015: 42 · 2014: 34 · 2013: 42 · 2012: 41
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- hereditary hemochromatosis, HFE gene, iron overload, iron metabolism genes, disease management, diabetes mellitus, liver cirrhosis
- MeSH terms
- Hemochromatosis Protein, Genotype, Hemochromatosis, Homeostasis, Humans, Iron, Membrane Proteins, Mutation, Phenotype, Receptors, Transferrin, Histocompatibility Antigens Class I, Iron Overload, Antimicrobial Cationic Peptides, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review